Arrestins and Protein Ubiquitination - Progress in Molecular Biology and Translational Science - page 194

18. Pearse BM. Clathrin: a unique protein associated with intracellular transfer of mem-
brane by coated vesicles. Proc Natl Acad Sci USA . 1976;73:1255 - 1259.
19. Laporte SA, Oakley RH, Holt JA, Barak LS, Caron MG. The interaction of beta-
arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic recep-
tor into clathrin-coated pits. J Biol Chem . 2000;275:23120 - 23126.
20. Kirchhausen T, Nathanson KL, Matsui W, et al. Structural and functional division into
two domains of the large (100- to 115-kDa) chains of the clathrin-associated protein
complex AP-2. Proc Natl Acad Sci USA . 1989;86:2612 - 2616.
21. Drake MT, Shenoy SK, Lefkowitz RJ. Trafficking of G protein-coupled receptors. Circ
Res . 2006;99:570 - 582.
22. Shenoy SK, Lefkowitz RJ. Beta-arrestin-mediated receptor trafficking and signal trans-
duction. Trends Pharmacol Sci . 2011;32:521 - 533.
23. Luttrell LM, Ferguson SS, Daaka Y, et al. Beta-arrestin-dependent formation of beta2
adrenergic receptor-Src protein kinase complexes. Science . 1999;283:655 - 661.
24. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG.
An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotrans-
mission and behavior. Cell . 2005;122:261 - 273.
25. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW. Beta-
arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intra-
cellular targeting of activated ERK1/2. J Cell Biol . 2000;148:1267 - 1281.
26. McDonald PH, Chow CW, Miller WE, et al. Beta-arrestin 2: a receptor-regulated
MAPK scaffold for the activation of JNK3. Science . 2000;290:1574- 1577.
27. Sun Y, Cheng Z, Ma L, Pei G. Beta-arrestin2 is critically involved in CXCR4-
mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activa-
tion. J Biol Chem . 2002;277:49212 - 49219.
28. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. Beta-arrestins and cell signaling. Annu
Rev Physiol . 2007;69:483 - 510.
29. Gesty-Palmer D, Flannery P, Yuan L, et al. A beta-arrestin-biased agonist of the para-
thyroid hormone receptor (PTH1R) promotes bone formation independent of
G protein activation. Sci Transl Med . 2009;1:1ra1.
30. Shenoy SK, Drake MT, Nelson CD, et al. Beta-arrestin-dependent, G protein-
independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem .
2006;281:1261 - 1273.
31. Violin JD, Lefkowitz RJ. Beta-arrestin-biased ligands at seven-transmembrane recep-
tors. Trends Pharmacol Sci . 2007;28:416 - 422.
32. Wei H, Ahn S, Shenoy SK, et al. Independent beta-arrestin 2 and G protein-mediated
pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.
Proc Natl Acad Sci USA . 2003;100:10782- 10787.
33. HershkoA,Ciechanover A. The ubiquitin system. AnnuRevBiochem . 1998;67:425 - 479.
34. Shenoy SK. Seven-transmembrane receptors and ubiquitination. Circ Res . 2007;100:
1142- 1154.
35. Hochstrasser M. Evolution and function of ubiquitin-like protein-conjugation systems.
Nat Cell Biol . 2000;2:E153 - 157.
36. Deshaies RJ, Joazeiro CA. RING domain E3 ubiquitin ligases. Annu Rev Biochem .
2009;78:399 - 434.
37. Joazeiro CA, Weissman AM. RING finger proteins: mediators of ubiquitin ligase activ-
ity. Cell . 2000;102:549- 552.
38. Willis MS, Zungu M, Patterson C. Cardiac muscle ring finger-1—friend or foe? Trends
Cardiovasc Med . 2010;20:12 - 16.
39. Willems AR, Schwab M, Tyers M. A hitchhiker's guide to the cullin ubiquitin ligases:
SCF and its kin. Biochim Biophys Acta . 2004;1695:133 - 170.